chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The day of the vaccination I had soreness at the injection site.  That evening I had some night sweats, and I felt a bit tired the next day.  That was all expected.  Exactly one week later I had nausea, vomiting and diarrhea that lasted about 24 hours. For 24 hours after that I had a decreased appetite, and then after that I was fine.  Not sure if this was related to the vaccine but wanted to report it just in case.
white circles/splotches around injection sight, up her neck, onto her chest, back and down her arm to her elbow; white circles/splotches around injection sight, up her neck, onto her chest, back and down her arm to her elbow; This is a spontaneous report from a contactable pharmacist. A 57-years-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot Number: EL3302), via intramuscular route of administration, administered in Arm Right on 24Feb2021, at 12:00 (Age at vaccination 57-years-old), as DOSE 2, SINGLE for covid-19 immunization. Patient did not receive other vaccine in four weeks. Patient did not have covid-19 prior to vaccination. After vaccination patient was not tested for covid. The patient medical history was not reported. Concomitant medications included zinc chloride (ZINC CHLORIDE), colecalciferol (VITAMIN D 3) taken for an unspecified indication, start and stop date were not reported. The patient had allergies from amoxicillin, augmentin bd, tetracycline, erythromycin. The patient previously received first dose of of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot Number: EL3302), via unspecified route of administration, administered in Arm left on 03Feb2021 (Age at vaccination 57-years-old), as DOSE 1, SINGLE for covid-19 immunization. The patient experienced white circles/splotches around injection sight on 24Feb2021 at 20:00. The patient had white circles/splotches around injection sight, up her neck, onto her chest, back and down her arm to her elbow. they were not raised and did not itch. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event was recovering.   Follow-up attempts completed. No further information expected.
TEMP EXCURSION- ROOM TEMP(68*) FOR >12 HOURS. NO SIDE EFFECTS REPORTED BY PATIENT
Patient reported for second moderna covid shot and representative of patient stated the patient developed a hive-like rash  (stated about 4 inch diameter) mostly around the injection site but some very light "hive-like" patches on the arm and that it was very light in color (wouldn't show up on pictures); she stated it did not cause any problems and they watched it-pt applied warm compress (pt did not seek medical treatment treatment or advice); pt took tylenol the first night.  Patient waited 30+ minutes after second dose for observation. No current issues.
Pain in the left testicle; Nodule in the left testicle; This spontaneous case was reported by a consumer and describes the occurrence of   in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included Prostate cancer and Testicular disorder (testicular nodules).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient started on Antibiotics as treatment. No relevant concomitant medications were reported.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Myalgia; Arthralgia; Headache; Extreme fatigue; Low grade fever; This spontaneous case was reported by a physician and describes the occurrence of MYALGIA (Myalgia), ARTHRALGIA (Arthralgia), HEADACHE (Headache), FATIGUE (Extreme fatigue) and PYREXIA (Low grade fever) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced MYALGIA (Myalgia), ARTHRALGIA (Arthralgia), HEADACHE (Headache), FATIGUE (Extreme fatigue) and PYREXIA (Low grade fever). On 17-Jan-2021, MYALGIA (Myalgia), ARTHRALGIA (Arthralgia), HEADACHE (Headache), FATIGUE (Extreme fatigue) and PYREXIA (Low grade fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drug was not reported. Treatment medication was not reported.   This case was linked to MOD-2021-257968 (Patient Link).
bent down and fell and hit the floor; dizzy/ light headedness; nauseous; slept all day; he tests his sugar every morning/ it was 54; This is a spontaneous report received from a contactable consumer for a Pfizer sponsored program. The reporter is the patient.  A 61-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the left arm, administration date 15Mar2021 11:45 (Lot number: EN6208) at the age of 61 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "hypoglycemic", start date: 2013 (unspecified if ongoing), notes: for the past eight years and tries to control that with diet; "acid reflux" (unspecified if ongoing); "heartburn" (unspecified if ongoing); "allergy" (unspecified if ongoing); "sneezes" (unspecified if ongoing). Concomitant medications included: PANTOPRAZOLE taken for dyspepsia, gastrooesophageal reflux disease, start date: 2011; CETIRIZINE taken for hypersensitivity, sneezing. Vaccination history included: BNT162B2 (dose 1, administered in the left arm, Lot number: EN6200), administration date: 22Feb2021 14:00, when the patient was 61 years old, for COVID-19 immunisation; Flu shot, administration date: Nov2020, for immunisation. The following information was reported: DIZZINESS (non-serious) with onset 16Mar2021, outcome "not recovered", described as "dizzy/ light headedness"; NAUSEA (non-serious) with onset 16Mar2021, outcome "not recovered", described as "nauseous"; FATIGUE (non-serious) with onset 16Mar2021, outcome "unknown", described as "slept all day"; HYPOGLYCAEMIA (non-serious) with onset 16Mar2021, outcome "unknown", described as "he tests his sugar every morning/ it was 54"; FALL (non-serious) with onset 17Mar2021, outcome "unknown", described as "bent down and fell and hit the floor". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient has no family history. He has no history of all previous immunisation with the Pfizer vaccine considered as suspect and additional vaccines administered on the same date of the Pfizer suspect. The events did not require a visit to physician or ER. On 17Mar2021, The patient went back to work but he felt nauseous and dropped something from the tool box and bent over to pick it up and the next thing he knew he was on the ground. He didn't think he passed out but he was just that light headed.  No follow-up attempts are possible. No further information is expected.
pt recv vax & 3hr later exp fever, diff swallowing & swollen glands;sx resolved w/in a week;
Got the vaccine around 845am by 130 I was feeling nausea, by 3 I was experiencing nausea, body aches, chills, and headache and fatigue. I was able to sleep over night but woke up this morning with nausea, fatigue, headache, dizziness, and body aches.
Myalgia, Fever, PAIN AT LEFT DELTOID, SWOLLEN AND RED Narrative:
Patient was vaccinated on 6/7/2021. She experienced pain at injection site.  On 6/9/21 she developed a bright red, swollen, warm, heart-shaped "hive" at the injection site.   Pt denies pain.  This was pt's 2nd injection.  No reaction felt or observed with first injection.
This spontaneous report was received from a other health professional referring to an unspecified group of child patients. Information regarding the patients' pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. On an unknown date, the patients' were vaccinated with M-M-R II (anatomical route of vaccination, lot # and expiration date were not provided) for prophylaxis. It was reported that, on an unknown date, an outbreak of mumps occurred at the school. It was unknown how many children were involved or if any children were vaccinated with M-M-R II. At the time of the report, the outcome of mumps and the causality between the reported event and vaccination with M-M-R II were unknown.
Patient c/o numbness in Bilateral hands after vaccination.  Patient stated he did not eat before receiving vaccine.  Patient's blood pressure was 149/100 (@12:51pm).  Patient can not open his hands (bilateral).  EMS was called due to hyperventilating.  EMS was given report.  EMS checked blood pressure (152/92).  Patient stated he does have panic attack to EMS.  Blood sugar (114) Heart rate check:  1st time (127), 2nd time  at 12:53pm (96).  Blood press checked by EMS was 148/90.  Patient was given orange juice and some snacks.  EMS had stated patient did not need to go the ER at all.  Patient was allowed to rest at the site until 01:30pm, and left on his own.
Rash on her arm; Itchy Sensation Rash - Near Injection Site; Red Rash - Near Injection Site/ Bright Red, Triangular Shaped Rash - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy Sensation Rash - Near Injection Site), RASH (Rash on her arm) and INJECTION SITE RASH (Red Rash - Near Injection Site/ Bright Red, Triangular Shaped Rash - Near Injection Site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE RASH (Red Rash - Near Injection Site/ Bright Red, Triangular Shaped Rash - Near Injection Site). On 28-Jan-2021, the patient experienced RASH PRURITIC (Itchy Sensation Rash - Near Injection Site). On an unknown date, the patient experienced RASH (Rash on her arm). The patient was treated with OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) at a dose of UNK dosage form. On 23-Jan-2021, INJECTION SITE RASH (Red Rash - Near Injection Site/ Bright Red, Triangular Shaped Rash - Near Injection Site) had resolved. At the time of the report, RASH PRURITIC (Itchy Sensation Rash - Near Injection Site) and RASH (Rash on her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided. Other treatment included antibiotics.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow-up received and added new event.
7 days after injection, injection site became warm to touch, hard and itchy/at times feeling similar to a bee sting. Benadryl was taken to minimize the itch/stinging sensation. 12 hours, stinging sensations are gone and mild, reduced itch. Skin still warm to touch and hard.
Occasional numbness or tingling in arm with shot. Comes and goes. Spoke with client originally at 11:15 over phone. PT spoke with doctor over phone. Called back at 230. Symptoms improving. no further care requested.
Serum Sickness-Like Reaction:  rash starting 5days after vaccine administration at legs, starting as red bumps then spreading out in red wheals 2x3cm approx from legs to trunk, face with no respiratory compromise.  No swelling of lips, tongue, throat, no cough, no pharyngitis.  Resolved after 4d of rash.
reported ROTATEQ was given past 32 weeks of age to a patient. No adverse symptoms reported.; reported ROTATEQ was given past 32 weeks of age to a patient. No adverse symptoms reported.; This spontaneous report was received from an administrator and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On 13-SEP-2019, the patient, who was past 32 weeks of age, was vaccinated with a dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally, for prophylaxis (lot/batch # and expiration date were not reported). No adverse symptoms reported. No further information provided.
got the vaccine, got shingles / suspected vaccination failure; shingles in his eyes; hurting; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant) and pain. On an unknown date, the outcome of the vaccination failure, ophthalmic herpes zoster and pain were unknown.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster and pain to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient's wife. The age at vaccination was not reported. The reporter stated that both got the vaccine a year before day of reporting. Now the patient got shingles in his eye. The vaccine did not stop it, it prevents it from being so severe. But he was a hurting unit. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
Erythema, induration & warmth to oval epidermal region adjacent to vaccine administration RUE, 5cm x 4cm
Pt received vaccine and was sitting in observation for 10 minutes when he started to complain of feeling really warm, skin was flush and he was sliding out of his chair.  Pt was assisted to stand and move to another room to lay down and have vital signs taken. During this move he passed out and was assisted to the ground.  Pt did not hit his head and was laid flat.  At this time emergency protocol was activated and Epi Pen was given to left thigh at 10:42. BP 127/64 P. 64 SPO2 100%. respiration shallow at 18.  Pt opened eyes immediately after Epi pen administration.  He had no recall of syncopal episode.  Pt was transported to ER via ambulance for further evaluation.
PT DEVELOPED PAIN IN RIGHT SHOULDER/ DELTOID EVENING AFTER RECEIVING VACCINE ON  10-01-2020.  PAIN HAS CONTINUED UP TO CURRENT DATE 12-11-2020. PAIN MOSTLY AFFECTED RIGHT DELTOID MUSCLE, PAIN ALSO RADIATING TO INNER ARM/AXILLA OF RIGHT ARM.
Bad cramps followed by diarrhea for 10 days, never had strange stomach pains like that.
Varicella - Information has been received from a healthcare professional concerning a 44 month old female who was vaccinated on 11 Jul 1997 with one dose of varicella virus vaccine live (unknown site) on 18 mar 2000 the patient developed lesions and on 20 mar 2000 the patient was diagnosed with chicken pox. the patient has 25-30 lesions on back, stomach, face, neck. the patient sought unknown medical attention.
Numbness of toes on 10/28/14, on 11/03/2014, weakness of legs and arms, 11/04/2014, balance and coordination off and tingling of finger tips and jaw pain.
This spontaneous report was received from an unspecified reporter via an online article published and refers to a 278 patients of unknown age and gender who reported the events via Vaccine Adverse Event Reporting System. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with doses of quadrivalent HPV (manufacturer unknown) (dose, route of administration, anatomical location, lot # and expiration date were not reported). On unknown dates, the patients experienced unspecified adverse events that required an extended hospital stay (start and stop dates and duration of hospitalization were not reported). The outcome of adverse events was unknown. the relatedness between the events and quadrivalent HPV (manufacturer unknown) was not reported. This is one of several reports received from the same reporter. Additional information is not expected as no contact details were provided.
I did not get my menstrual cycle come on for seven weeks post the first vaccine.This is the longest time I have ever not got my period.(as a note, I also took three pregnancy tests that were all negative)    Following my second vaccine I have still not gotten my period.   Even more concerning I have been having severe joint pain in my hands that I have never had before in my entire life. Also some additional  pain seems arthritic that I have never had before.
Patient reported muscle weakness and dizziness starting at 1415. Vital signs at this time were as follows: 117/75 mm Hg, Pulse 90 bpm, oxygen saturation 98%,  and respiratory rate 18 bpm. RN noted muscle weakness in extremities, and sweating. Patient reported dizziness and feeling like she would pass out. Vital signs at 1420 were as follows: 114/75 mm Hg, pulse 109 bpm, oxygen saturation 99%, and respiratory rate 20 bpm. Patient reported not eating food, or drinking water recently.  Patient  was provided water and candy, and had persistent numbness and weakness in extremities.  Paramedics were called to assess patient. Paramedics assessed and found patient not meeting medical necessity (vital signs WNL). Patient signed medical wavier paramedics provided. Vital signs were as follows: 117/73 mm Hg, Pulse 91 bpm, and oxygen saturation 99%. Patient reported "feeling better, and wanting to go home." Paramedics escorted patient to her car, along with her husband. Patient was provided information to call medical professional if symptoms worsen.
Moderna COVID vaccine booster dose of 0.25mL but the dose was expired; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID vaccine booster dose of 0.25mL but the dose was expired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID vaccine booster dose of 0.25mL but the dose was expired). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna COVID vaccine booster dose of 0.25mL but the dose was expired) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment medications were reported.
Patient reported numbness and tingling on the tongue 5 minutes after receiving the COVID-19 vaccine, she has a history of anaphylactic reaction to sulfa, epi pen administered at 13:50pm. Took by ambulance to emergency room at 14:10pm today
A nurse reported that a 2 month old infant received the first dose of Prevnar (pneomococcal 7 valent conjugate vaccine (diphtheria crm197 protein)) on 11 MAR 2002. On 13 MAR 2002, the infant developed generalized hives all over the body and right ear swelling and was referred to a dermatologist. The symptoms were reported to have abated. No further information was available as of the date of this report.
This 16-year-old patient inadvertently received a pediatric dose of Pfizer (10 mcg/0.2 mL) which is approved for ages 5-11.  Patient was observed for the recommended 15 minutes with no adverse reactions.
Red and tender at vaccination site Swollen lymph nodes in armpit that are tender to the touch
Few days after receiving the 1st dose, developed tingling paresthesia in both hands. He received his second vaccination  despite the symptoms.  Symptoms continued to progress to his feet, and also developed weakness, particularly in his legs.  Also had some weakness in arm but more so on the left side.  He had difficulty climbing ladder when deer hunting due to weakness in his thighs/legs.  He ended up falling in his home on Jan 17, 2021 as well, which caused significant hip pain.  Had a neurosurgical evaluation- finding lumbar disease L3-4 requiring fusion.  Following surgery, paresthesia and weakness persisted and  actually worsened, , developed uncontrolled twitching in both thighs.  Further developed loss of function in his L-hand.  MRI revealed transverse myelitis.  Symptoms have improved with corticosteroid therapy.  Patient was hospitalized due to these symptoms for two days, discharged on corticosteroids.
About an hour later I felt dizzy and a little disillusioned.   I did experience the expected migraines and nausea.  I also had chills and lost of appetite.
Around July 1, 2022, I had a very sore throat and the cough that went with it, extreme headaches, sneezing, and taste and smell issues. I still have taste and smell issues. I was prescribed PAXLOVID on July 3, 2022.
1 week post dose patient still having severe pain in right deltoid. very tender to touch and red at injection site
This patient had swelling right of her injection site, red with streaking into anterior shoulder, hot to touch, red translucent, large patch 4" x 5" anterior medial middle 1/3 of upper arm. Distal ok, temp 98.4.
Employee symptomatic with loss smell and taste 6/22/21. Tested Covid positive  on 6/22/21.
Patient has swelling and redness with 3 inch diameter around injection site. She states that it is warm to the touch. She also sees redness on forearms. I advised her to contact her doctor right away or go to urgent care to have it looked at.
3"x3" lump under skin at injection site still 10/13/06. Headache & left side body/neck pain on 10/10 lasting few hours.
Pt. states after receiving J&J vaccine 03/24/2021, started experiencing on  06/15/2021 tingling, itchiness, head pain, neuropathy. Still continuing.
Arm still sore after immunization. Describes pain as "4". No redness, or heat or swelling reported.
Swelling, pain, itching at left deltoid x one day.  10x11 cm area of erythema on exam.
pt recv vax 30OCT96 & on 2JUN97 pt exp chickenpox;pt recovered;
Patient began feeling tongue swelling, tightness in throat, progressed to headache, flushing, chest tightness. Patient refused 911-EMS. Ambulated to ER, escorted by RN.
Chills, aches, fever max 100.3 post second dose Pfizer COVID vaccine. Patient was followed up with on 1/8/2021 and the patient stated that his symptoms had resolved. No further escalation of care.